HomeQuestion

How do you treat muscle invasive bladder cancer with neuroendocrine differentiation?

1

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Are you dose reducing/omitting IV dexamethasone as a pre-medication for anti-emesis in patients with MIBC when using durvalumab/gemcitabine/cisplatin?

How would do manage stage II/III Muscle invasive bladder cancer with large cell neuroendocrine histology?

Would you use T-DXd as a first-line agent for a patient who developed early metastatic relapse of HER2+ urothelial cancer shortly after standard perioperative chemo/immunotherapy, over other standard non-targeted treatments?

Would you consider utilizing pembrolizumab/enfortumab as a bladder preservation approach in patients with MIBC?

Do the results of IMvigor011 influence you to utilize ctDNA to guide all adjuvant IO in MIBC?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.

How do you treat muscle invasive bladder cancer with neuroendocrine differentiation? | Mednet